We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+9.15%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$630M
AUM Growth
+$19.1M
Cap. Flow
-$22.7M
Cap. Flow %
-3.61%
Top 10 Hldgs %
32.12%
Holding
186
New
13
Increased
53
Reduced
79
Closed
17

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$4.6M
2
LOW icon
Lowe's Companies
LOW
+$4.54M
3
GNRC icon
Generac Holdings
GNRC
+$4.05M
4
ZBH icon
Zimmer Biomet
ZBH
+$3.64M
5
CHWY icon
Chewy
CHWY
+$2.07M

Sector Composition

Rank Sector Weight
1 Technology 30.19%
2 Healthcare 17.08%
3 Industrials 16.64%
4 Utilities 9.87%
5 Energy 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRC icon
51
Gorman-Rupp
GRC
$2.23B
$4.25M 0.67%
119,604
-1,854
-2% -$59.8K
KNF icon
52
Knife River
KNF
$3.83B
$4.13M 0.65%
62,336
-483
-0.8% -$27.5K
IDA icon
53
Idacorp
IDA
$8.15B
$4.08M 0.65%
41,518
-200
-0.5% -$19.4K
ZBH icon
54
Zimmer Biomet
ZBH
$18.8B
$3.98M 0.63%
+32,664
New +$3.64M
VOO icon
55
Vanguard S&P 500 ETF
VOO
$1.01T
$3.83M 0.61%
8,779
+756
+9% +$310K
COHR icon
56
Coherent
COHR
$65.4B
$3.7M 0.59%
85,100
+9,100
+12% +$328K
STT icon
57
State Street
STT
$50.8B
$3.63M 0.58%
46,810
+5,100
+12% +$356K
AAPL icon
58
Apple
AAPL
$4.56T
$3.49M 0.55%
18,143
+972
+6% +$179K
ABT icon
59
Abbott
ABT
$187B
$3.41M 0.54%
30,974
+130
+0.4% +$13K
GE icon
60
GE Aerospace
GE
$389B
$3.31M 0.53%
32,503
-566
-2% -$52.4K
GSK icon
61
GSK
GSK
$104B
$3.29M 0.52%
88,740
+12,160
+16% +$437K
APTV icon
62
Aptiv
APTV
$9.61B
$3.19M 0.51%
35,500
-9,750
-22% -$840K
AMGN icon
63
Amgen
AMGN
$219B
$3.11M 0.49%
10,814
-130
-1% -$35.4K
LITE icon
64
Lumentum
LITE
$65.2B
$3.08M 0.49%
58,691
-55,700
-49% -$2.43M
EA icon
65
Electronic Arts
EA
$3.02M 0.48%
22,050
+550
+3% +$72.7K
NRG icon
66
NRG Energy
NRG
$25.1B
$2.72M 0.43%
52,550
-950
-2% -$42.9K
A icon
67
Agilent Technologies
A
$39.9B
$2.64M 0.42%
18,976
-2,476
-12% -$295K
CCK icon
68
Crown Holdings
CCK
$13.2B
$2.63M 0.42%
28,589
-145
-0.5% -$12.3K
ARCB icon
69
ArcBest
ARCB
$3.02B
$2.61M 0.41%
21,750
-350
-2% -$38.8K
VNM icon
70
VanEck Vietnam ETF
VNM
$504M
$2.54M 0.4%
196,300
+10,150
+5% +$132K
PEG icon
71
Public Service Enterprise Group
PEG
$37.4B
$2.53M 0.4%
41,394
-475
-1% -$29.2K
BKH icon
72
Black Hills Corp
BKH
$5.54B
$2.53M 0.4%
46,880
-83,375
-64% -$4.28M
CHWY icon
73
Chewy
CHWY
$9.59B
$2.48M 0.39%
+104,889
New +$2.07M
PYPL icon
74
PayPal
PYPL
$51.1B
$2.41M 0.38%
39,285
+6,400
+19% +$367K
INST
75
DELISTED
Instructure Holdings, Inc.
INST
$2.39M 0.38%
88,464
+75,613
+588% +$1.96M

Similar funds

John G. Ullman & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, John G. Ullman & Associates held 186 positions worth $630M, up 3.1% from $611M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

John G. Ullman & Associates withdrew a net $22.7M in Q4 2023, closing 17 positions and reducing 79 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $9.11M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, John G. Ullman & Associates opened a new position in Lowe's Companies worth $4.98M.

  • John G. Ullman & Associates's largest Q4 2023 buy was Lowe's Companies: 22,375 shares worth $4.98M.
  • John G. Ullman & Associates added most to Broadcom in Q4 2023, an estimated $4.6M increase.
  • John G. Ullman & Associates's biggest Q4 2023 reduction was Aecom, cutting an estimated $6.65M.
  • John G. Ullman & Associates fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $9.11M.
  • John G. Ullman & Associates's ten largest holdings make up 32% of its $630M portfolio in Q4 2023.
  • John G. Ullman & Associates opened 13 new positions and closed 17 in Q4 2023.
  • John G. Ullman & Associates's portfolio value rose 3.1% quarter-over-quarter to $630M.

Based on John G. Ullman & Associates's 13F filing for Q4 2023, filed 31 Jan 2024.